MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Meyer FP et al. | [Intra-individual comparison of the long term effect of Non-Ovlon on caffeine pharmacokinetics]. | 1988 | Zentralbl Gynakol | pmid:2464882 |
Krafft W | [Therapy of juvenile adenomatous hyperplasia of the endometrium by progesterone stimulation]. | 1989 | Zentralbl Gynakol | pmid:2475003 |
Mueck AO et al. | [Effect of tibolone on vascular markers of human female coronary arteries - comparison with estradiol/norethisterone]. | 2001 | Zentralbl Gynakol | pmid:11797164 |
Löttge M et al. | [Case report of Fox-Fordyce disease]. | 1988 | Zentralbl Gynakol | pmid:3414213 |
Hempel E et al. | [Enzyme induction by drugs and hormonal contraception]. | 1973 | Zentralbl Gynakol | pmid:4129505 |
Schindler C | [Use of gestagens to control in vitro growth of endometrial carcinoma (author's transl)]. | 1981 | Zentralbl Gynakol | pmid:7223173 |
Krafft W et al. | [Efficacy of an adjuvant norethisterone acetate therapy (NEA) of endometrial carcinoma treated with primary surgery or irradiation]. | 1990 | Zentralbl Gynakol | pmid:2220176 |
Schindler C and Schober J | [Results obtained from gestagen treatment of patients for endometrial carcinoma, with particular reference to results obtained from in vitro tests before treatment (author's transl)]. | 1981 | Zentralbl Gynakol | pmid:7282171 |
Behling H et al. | [Effectivity of long-term high dose norethisterone treatment of corpus uteri carcinoma patients. Results of a prospective randomized study]. | 1983 | Zentralbl Gynakol | pmid:6880470 |
Krafft W et al. | [Problems in the therapy of ovarian carcinoma with gestagen-acting hormones]. | 1983 | Zentralbl Gynakol | pmid:6880471 |